Treating Advanced Solid Tumors in People with Inherited PTEN Mutations Using the Investigational Drug TAS-117
People with advanced cancer and an inherited PTEN mutation
Clinicaltrials.gov identifier:NCT04770246
Study Contact Information:
For additional information, please contact:
Osamu Takahashi, MD, PhD by phone: 609-250-7336 or by email at: [email protected]
About the Study
This study will look at how well the TAS-117 works for treating people with an inherited mutation and advanced or solid tumors (excluding primary brain tumors). NOTE: this study is no longer enrolling people.
This Study is Open To:
NOTE: this study is no longer enrolling people.
This Study is NOT Open To:
NOTE: this study is no longer enrolling people.
Study Contact Information:
For additional information, please contact:
Osamu Takahashi, MD, PhD by phone: 609-250-7336 or by email at: [email protected]
People with advanced cancer and an inherited PTEN mutation
Clinicaltrials.gov identifier:NCT04770246
Study Contact Information:
For additional information, please contact:
Osamu Takahashi, MD, PhD by phone: 609-250-7336 or by email at: [email protected]